Vogenx Inc Company Profile
NASDAQ: VOGXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Vogenx at a glance
Vogenx Inc (NASDAQ: VOGX) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Raleigh, NC. Vogenx is led by Mr. James Green and employs about 4 people. The company's shares have traded publicly since 2026.
At a market capitalization of $259.8 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001903784, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Vogenx do?
Vogenx, Inc. operates as a clinical-stage drug development company that develops therapeutics for metabolic including post-bariatric hypoglycemia, or PBH, and gastroparesis. Its products include drugs, such as Mizagliflozin and VGX-2857. It also offers VGX-001, a human monoclonal antibody for the treatment of type 1 diabetes (T1D). It caters to healthcare providers, physicians and third-party payors in the United States. The company was incorporated in 2021 and is based in Raleigh, North Carolina.
Business description based on the company's public filings.
Company information
- Legal name
- Vogenx Inc
- Ticker
- NASDAQ: VOGX
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. James Green
- Employees
- 4
- Headquarters
- 3901 Barrett Drive, Raleigh, NC, United States
- Phone
- 919 659 5677
- Website
- vogenx.com
- IPO year
- 2026
- Market cap
- $259.82M
- SEC CIK
- 0001903784
Companies similar to Vogenx
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ACIUAC Immune SA | 2.55 | -0.78% | $253.54M | vs VOGX |
| AMRNAmarin Corporation plc | 11.99 | -0.25% | $253.26M | vs VOGX |
| VCREVicore Pharma Holding AB ADR | 8.82 | +1.85% | $248.41M | vs VOGX |
| BBOTBridgeBio Oncology Therapeutics Inc. | 3.42 | -0.58% | $274.20M | vs VOGX |
| LFCRLifecore Biomedical Inc. | 6.43 | -0.16% | $243.73M | vs VOGX |
| IMRXImmuneering Corporation Class A | 3.74 | -3.11% | $241.97M | vs VOGX |
| QTTBQ32 Bio Inc. | 8.09 | +1.25% | $240.83M | vs VOGX |
| ABEOAbeona Therapeutics Inc. | 4.96 | -2.36% | $283.63M | vs VOGX |